Prijeđi na sadržaj

Amoksapin

Izvor: Wikipedija
Amoksapin
(IUPAC) ime
2-hloro-11-(piperazin-1-il)dibenzo[b,f][1,4]oksazepin
Klinički podaci
Robne marke Asendin
AHFS/Drugs.com Monografija
MedlinePlus a682202
Identifikatori
CAS broj 14028-44-5
ATC kod N06AA17
PubChem[1][2] 2170
DrugBank DB00543
ChemSpider[3] 2085
UNII R63VQ857OT DaY
KEGG[4] D00228 DaY
ChEBI CHEBI:2675 DaY
ChEMBL[5] CHEMBL1113 DaY
Hemijski podaci
Formula C17H16ClN3O 
Mol. masa 313,781 g/mol
SMILES eMolekuli & PubHem
Farmakokinetički podaci
Bioraspoloživost ?
Vezivanje za proteine plazme 90%[6]
Metabolizam Hepatički (citohrom P450)
Poluvreme eliminacije 8-10 sata (30 sata za glavne metabolite)[6]
Izlučivanje Renal
Farmakoinformacioni podaci
Trudnoća C(US)
Pravni status -only (SAD)
Način primene Oralnot

Amoksapin (Amokisan, Asendin, Asendis, Defanil, Demoloks, Moksadil) je tetraciklični antidepresiv iz dibenzoksazepinske familije, mada se on često klasifikuje kao sekundarni aminski triciklični antidepresiv. On je N-demetilisani metabolit Loksapina.

Farmakologija

[uredi | uredi kod]

Amoksapin ispoljava mnoštvo farmakoloških efekata. On je umeren i jak inhibitor preuzimanja serotonina i norepinefrina, respektivno,[7] i vezuje se za 5-HT2A,[8] 5-HT2B,[9] 5-HT2C,[8] 5-HT3,[10] 5-HT6,[11] 5-HT7,[11] D2,[12] α1-adrenergički,[12] D3[13], D4,[13] i H1 receptor[12] sa promenljivim ali značajnim afinitetom, na njijima deluje kao antagonist (ili inverzni agonist u zavisnosti od receptora) na svim aktivnim mestima. On ima slab i zanemarljiv afinitet za dopaminski transporter i 5-HT1A,[10] 5-HT1B,[10] D1,[14] α2-adrenergički,[12] H4,[15] mACh,[12] i GABAA receptor,[14] i nema afiniteta za β-adrenergičke receptore ili za alosterna benzodiazepinska mesta na GABAA receptoru.[14]

Reference

[uredi | uredi kod]
  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.  edit
  4. Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H. 
  5. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.  edit
  6. 6,0 6,1 Kinney JL, Evans RL (1982). „Evaluation of amoxapine”. Clinical Pharmacy 1 (5): 417–24. PMID 6764165. 
  7. Tatsumi M, Groshan K, Blakely RD, Richelson E (December 1997). „Pharmacological profile of antidepressants and related compounds at human monoamine transporters”. European Journal of Pharmacology 340 (2–3): 249–58. DOI:10.1016/S0014-2999(97)01393-9. PMID 9537821. 
  8. 8,0 8,1 Pälvimäki EP, Roth BL, Majasuo H, et al. (August 1996). „Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor”. Psychopharmacology 126 (3): 234–40. DOI:10.1007/BF02246453. PMID 8876023. 
  9. Glusa E, Pertz HH (June 2000). „Further evidence that 5-HT-induced relaxation of pig pulmonary artery is mediated by endothelial 5-HT2B receptors”. British Journal of Pharmacology 130 (3): 692–8. DOI:10.1038/sj.bjp.0703341. PMC 1572101. PMID 10821800. 
  10. 10,0 10,1 10,2 Gozlan H, Saddiki-Traki F, Merahi N, Laguzzi R, Hamon M (December 1991). „[Preclinical pharmacology of amoxapine and amitriptyline. Implications of serotoninergic and opiodergic systems in their central effect in rats]” (French). L'Encéphale 17 Spec No 3: 415–22. PMID 1666997. 
  11. 11,0 11,1 Roth BL, Craigo SC, Choudhary MS, et al. (March 1994). „Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors”. The Journal of Pharmacology and Experimental Therapeutics 268 (3): 1403–10. PMID 7908055. 
  12. 12,0 12,1 12,2 12,3 12,4 Richelson E, Nelson A (July 1984). „Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro”. The Journal of Pharmacology and Experimental Therapeutics 230 (1): 94–102. PMID 6086881. Arhivirano iz originala na datum 2021-08-28. Pristupljeno 2014-04-05. 
  13. 13,0 13,1 Burstein ES, Ma J, Wong S, et al. (December 2005). „Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist”. The Journal of Pharmacology and Experimental Therapeutics 315 (3): 1278–87. DOI:10.1124/jpet.105.092155. PMID 16135699. 
  14. 14,0 14,1 14,2 Wei HB, Niu XY (1990). „[Comparison of the affinities of amoxapine and loxapine for various receptors in rat brain and the receptor down-regulation after chronic administration]” (Chinese). Yao Xue Xue Bao = Acta Pharmaceutica Sinica 25 (12): 881–5. PMID 1966571. 
  15. Lim HD, van Rijn RM, Ling P, Bakker RA, Thurmond RL, Leurs R (September 2005). „Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist”. The Journal of Pharmacology and Experimental Therapeutics 314 (3): 1310–21. DOI:10.1124/jpet.105.087965. PMID 15947036. Arhivirano iz originala na datum 2019-12-13. Pristupljeno 2014-04-05. 

Povezano

[uredi | uredi kod]

Vanjske veze

[uredi | uredi kod]
pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy